Merck & Company, Inc. Common Stock — Quarterly Financial Statistics (NYSE:MRK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Quarterly Annual

Cash from operating activities 2.5 B3.29 B7.82 B2.86 B3.92 B5.37 B 19.97 B Cash from investing activities -1.49 B-770 M-283 M-11.2 B-10.21 B-5.6 B -27.3 B Cash from financing activities -5.75 B-3.56 B2.64 B4.75 B-2.98 B1.76 B 6.17 B Free cash flow 2.5 B3.29 B6.83 B1.82 B2.93 B4.48 B 16.06 B

News

Cathie Wood Buys $3.6M of HOOD, Sells $2.9M of 2 High-Growth Stocks – September 5 - TipRanks.com

Nike: Just Not Doing It (NKE)

Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know

SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China

The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.

Indian shares may open higher as traders trim Fed hike bets

Why Moderna's (MRNA) Cancer Vaccine Matters To Investors

Summit Packs A Punch For Merck's Keytruda — But Not Everyone Is Sold

Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?

Why Is Merck (MRK) Up 18.2% Since Last Earnings Report?

Pfizer's Pipeline Strategy Centers on Obesity and Oncology

Why Is Summit Therapeutics Stock Soaring Today? - Summit Therapeutics (NASDAQ:SMMT)